Filter
News & Insights
- GroceryOn-Premise FoodserviceConvenience Store
James Beard Award Winners, Michelin-Starred Chefs, Mixologists and Beverage Experts Head to the National Restaurant Association Show
Read More - Private Capital
Beyond financial leverage: Finding the real fulcrum in PE-backed companies
Read More - Destination Marketing
Fifth Street DMC Expands into Carolinas with Acquisition
Read More - Private Capital
"AI is scary, but don't be scared of it": What are private market leaders saying about AI's biggest risks and opportunities?
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
The art of capturing better patient data: Designing trials around the lives of patients
Read More - Wealth & Investment Management
The largest asset and wealth management conference returns to Monaco
Read More - Private Capital
AI power constraints are the investment opportunity - regardless of adoption scenarios
Read More - Private Capital
Climate investing is moving from narrative to execution: A challenging sentiment towards 'green strategies'
Read More - Private Capital
Europe's energy security today, from supply security to systemic exposure: A Q&A with Yana Popkostova
Read More - Private Capital
Why financing strategy matters more in today’s private capital market
Read More - Wealth & Investment Management
How will firms differentiate in asset and wealth management over the next 5 years?
Read More - Wealth & Investment Management
Private markets are no longer the cherry on top
Read More - Risk ManagementWealth & Investment Management
War is just negotiation with artillery
Read More - Business Strategy & LeadershipInvestment in Biotech, MedTech & Digital HealthPartnering, Business Development & Licensing
LSX World Congress Europe Panel on Oncology’s Next Frontier: Future Opportunities in an Ever-Growing Market
Read More - Destination Marketing
Kireem Swinton Feels the Vibe as Visit Baltimore President and CEO
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Gilead’s $2.2bn buy of Ouro Medicines includes Galapagos alliance
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
‘Expect the unexpected’: Navigating biotech M&A in an unpredictable climate
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Spring has sprung: Laigo Bio closes $19.7m financing round for dual-target therapeutics
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
From quiet beginnings to global recognition: The BioNTech story
Read More - Risk Management
Resilience redefined: Cyber, AI and the new risk imperative
Read More
